
Network of New York City business incubators and accelerators run through NYU Tandon for early-stage ventures

Canadian life sciences company builder providing seed capital, lab facilities and talent programmes

Building new life sciences companies in Canada is the work of adMare BioInnovations, which partners with innovators and entrepreneurs to help them overcome early-stage hurdles. Its aim is to build a pipeline of investable life sciences companies with national and global impact, and it reinvests its returns into the Canadian life sciences industry.
The organisation works through three linked goals. Building companies means offering seed capital, drug development know-how and turnkey laboratory and office space, all intended to de-risk and speed up innovation. Building ecosystems means working with government, academic, industry and investment partners to strengthen the sector. Building talent means focused leadership and skills programs, including short courses delivered with the Canadian Alliance for Skills and Training in Life Sciences.
adMare has launched a therapeutics accelerator for early-stage ventures across Canada, aimed at helping young therapeutics companies grow through funding and expert support. Its community is a digital network of life science professionals, ranging from students to chief executives, spread across the country from coast to coast.
The firm has offices in Vancouver, Montreal and Toronto. Its investment team includes executives with long experience of life sciences venture capital and drug discovery, and the organisation says its leaders have been involved in the creation and financing of numerous life sciences companies. Its executive team has also served on the boards of several sector companies.
The organisation says it invests in Canadian life sciences from sea to sea. Its stated vision is for Canadian life sciences to lead the world, built on the country's scientific research excellence and on companies that improve patient lives.
adMare BioInnovations builds life sciences companies in Canada. It combines early-stage capital, scientific and drug development expertise, and specialised laboratory and office space. Its aim is to create a pipeline of investable Canadian companies and reinvest its returns into the sector.
Innovators and entrepreneurs in Canadian life sciences, plus government, academic, industry and investment partners. It works across Canada.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about adMare BioInnovations.
Similar listings buyers compare against this one.

Network of New York City business incubators and accelerators run through NYU Tandon for early-stage ventures

Venture capital investor in consumer internet and cloud software start-ups

A Toronto venture firm investing in early-stage Canadian B2B technology companies

Fintech-focused early-stage venture firm run by former fintech founders and operators

Independent European venture capital firm investing in early-stage companies developing new therapeutics

Pre-seed and seed venture firm that decides on startups after a short recorded video pitch

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Community and fund for technologists at the earliest stage of starting a company
Everything here links back to the same verified catalogue. Pick your next stop.